TY  - GEN
AU  - Tao,Yungan
AU  - Rezaï,Keyvan
AU  - Brain,Etienne
AU  - Etessami,Atoussa
AU  - Lusinchi,Antoine
AU  - Temam,Stephane
AU  - Urien,Saik
AU  - Van,Marie-Louise Vo
AU  - Vauzelle-Kervroedan,Françoise
AU  - Lokiec,François
AU  - Daly-Schveitzer,Nicolas
AU  - Bourhis,Jean
TI  - A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma
SN  - 1879-0887
PY  - 2011///0425
KW  - Administration, Oral
KW  - Carcinoma
KW  - drug therapy
KW  - Carcinoma, Squamous Cell
KW  - Cisplatin
KW  - administration & dosage
KW  - Combined Modality Therapy
KW  - Female
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms, Squamous Cell
KW  - Radiotherapy Dosage
KW  - Squamous Cell Carcinoma of Head and Neck
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.radonc.2010.11.008
ER  -